PacificHealth Laboratories, Inc.
PHLI · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Revenue | $6,915 | $7,201 | $7,995 | $7,236 |
| % Growth | -4% | -9.9% | 10.5% | – |
| Cost of Goods Sold | $3,927 | $4,037 | $4,774 | $4,212 |
| Gross Profit | $2,988 | $3,164 | $3,221 | $3,024 |
| % Margin | 43.2% | 43.9% | 40.3% | 41.8% |
| R&D Expenses | $47 | $4 | $0 | $151 |
| G&A Expenses | $2,156 | $2,754 | $3,201 | $3,542 |
| SG&A Expenses | $3,414 | $3,920 | $5,081 | $4,441 |
| Sales & Mktg Exp. | $1,259 | $1,166 | $1,880 | $899 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,462 | $3,924 | $5,081 | $4,592 |
| Operating Income | -$474 | -$760 | -$1,941 | -$2,040 |
| % Margin | -6.9% | -10.6% | -24.3% | -28.2% |
| Other Income/Exp. Net | -$12 | -$1 | $3 | $45 |
| Pre-Tax Income | -$486 | -$761 | -$1,938 | -$1,994 |
| Tax Expense | $0 | $6 | -$262 | $1 |
| Net Income | -$486 | -$761 | -$1,676 | -$1,994 |
| % Margin | -7% | -10.6% | -21% | -27.6% |
| EPS | -0.025 | -0.047 | -0.11 | -0.15 |
| % Growth | 47.2% | 57.1% | 26.7% | – |
| EPS Diluted | -0.025 | -0.047 | -0.11 | -0.15 |
| Weighted Avg Shares Out | 19,545 | 16,147 | 14,975 | 13,660 |
| Weighted Avg Shares Out Dil | 19,545 | 16,147 | 14,975 | 13,660 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $4 | $46 |
| Interest Expense | $15 | $6 | $5 | $1 |
| Depreciation & Amortization | $42 | $100 | $198 | $160 |
| EBITDA | -$430 | -$656 | -$1,735 | -$1,833 |
| % Margin | -6.2% | -9.1% | -21.7% | -25.3% |